Hospital Universitario de Getafe Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00503516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fundación para la Investigación Biomédica - Hospital Universitario de Getafe | Hospital Universitario de Getafe (Madrid)

Active Ingredients

Drugs in Phase 3 Trials (1)

megestrol (megace) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dementia (Phase 3)

Weight Loss (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1